SHMT2 and metabolic dysfunction-associated steatotic liver disease: Mouse genetics indicates that serine hydroxymethyltransferase 2 maintains hepatic methylation potential and plays stage-specific roles in the pathogenesis of non-alcoholic fatty liver disease.